COMMUNIQUÉS West-GlobeNewswire

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
07/05/2026
IM8 products, including Daily Ultimate Essentials, Daily Ultimate Longevity, and The Beckham Stack, to be integrated into Inter Miami’s training facility and made available to all players NEW YORK and MIAMI, May 07, [...]
InStride Health Sustains Outstanding Clinical Results in Third Annual Outcomes Report; Announces State Expansion Across East Coast
07/05/2026
97% of InStride patients demonstrate clinical improvement as company nearly doubled patient enrollment in 2025 ahead of continued state expansion BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- InStride Health , the leader in [...]
AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential
07/05/2026
Final UPMC Primary Endpoint Report Details Positive Data from Ovarian Cancer Clinical Trial Combining Ampligen, Pembrolizumab and Cisplatin OCALA, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE [...]
Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results
07/05/2026
– Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrome – Submitted Application to Japanese MHLW for Orphan Drug Designation (ODD) for QRX003; MHLW Confirmed QRX003 [...]
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
07/05/2026
US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark expansion of company’s coast - to - coast RLT manufacturing network – the largest in the US Expanded [...]
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption
07/05/2026
ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its CompuFlo® medical [...]
Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
07/05/2026
The Expected License Agreement Would Position Oragenics as the Only Company with Therapeutic Strategies Targeting TBI-Induced Inflammation on Both Sides of the Blood-Brain Barrier Sarasota, FL and San Diego, CA, May 07 [...]
Reporting of transactions in NTG’s shares made by persons discharging managerial responsibilities and persons closely associated with them
07/05/2026
Company announcement no. 15 – 26 7 May 2026 Reporting of transactions in NTG’s shares made by persons discharging managerial responsibilities and persons closely associated with them In accordance with section 19 of [...]
Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
07/05/2026
ATLANTA, May 07, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a company that focuses on developing new medicines to treat pain and neuropathy, today announced that it [...]
Willis Knighton Health Selects Commure as Enterprise Ambient Scribe AI Partner
07/05/2026
MOUNTAIN VIEW, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Commure , a leading healthcare technology company, today announced it has been selected by Willis Knighton Health as its enterprise Ambient AI partner. Following a [...]
Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline
07/05/2026
Proceeds support commercialization of Arbli ™ , the first FDA-approved ready-to-use oral suspension for hypertension; and REZENOPY ™ , life-saving opioid overdose emergency treatment Financing also drives early- and [...]
SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress
07/05/2026
Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console FORT LAUDERDALE, Fla., May 07 [...]
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
07/05/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 07, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement from Sarborg Limited regarding the filing of a new [...]
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
07/05/2026
New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicines Silo Pharma targets unmet need in a drug market with no FDA-approved therapies [...]
Biotech’s Next Wave May Already be in Motion
07/05/2026
Insider Bets on what may become a Brain Cancer Moonshot DENVER, May 07, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com and NeOnc Technology) - The biotech and pharma sector is entering one of its most pivotal periods [...]
Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026
07/05/2026
20+ presentations highlight expanding role in pediatric lung disease, treatment-response assessment, and pharma trial endpoints DURHAM, NC and LONDON, May 07, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage [...]
Tria Federal Unveils Integrated Solutions Platform and New Website
07/05/2026
Tria helps federal health agencies achieve their critical missions by navigating complex tradeoffs between cost, quality, and access to care ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Tria Federal has unveiled a [...]
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
07/05/2026
US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark expansion of company’s coast - to - coast RLT manufacturing network – the largest in the US Expanded [...]
Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA
07/05/2026
Official FDA meeting minutes and Phase 2 data provide guidance on the pivotal Phase 3 registration path for CAD-1005 in heparin-induced thrombocytopenia (HIT) PONTE VEDRA, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Cadrenal [...]

Pages